RF

Robert Figlin

4DMedical Limited | Non-Executive Director
Dr Figlin held the post of Medical Director of the Thoracic and Genitourinary Oncology Program in the Departments of Medicine, Surgery and Urology, and served as Program Director of Solid Tumor Developmental Therapeutics within the Cancer Center. Robert serves as Editor for Kidney Cancer Journal, and his studies have appeared in Clinical Cancer Research, Journal of Clinical Oncology, New England Journal of Medicine, The Lancet, JNCI, Lancet Oncology, and Journal of Urology, among others. He is Chair of the Medical Advisory Committee.

Company and Role

Company
Title
Tenure
Since
4DX
4DX
4DMedical Limited
  • Non-Executive Director
8yrs, 1mthDec 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
4DX
4DX
4DMedical Limited
14/01/25580,090N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
4DX
4DX
4DMedical Limited
14/01/25
Buy
60,147$0.520$31,276Conversion of securities
4DX
4DX
4DMedical Limited
14/01/25
Exercise
60,147$0.520$31,276Conversion of securities
4DX
4DX
4DMedical Limited
21/11/24
Issued
60,147$0.603$36,250Issue of securities